Akoya Biosciences Inc (AKYA)
3.21 +0.19 (+6.29%) 01/22/25 [NASDAQ]
3.06 x 100 3.21 x 600
Realtime by (Cboe BZX)
3.06 x 100 3.21 x 600
Realtime 3.21 unch (unch) 16:02 ET
for Wed, Jan 22nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 18,814 | 23,164 | 18,350 | 26,487 | 25,215 |
Cost of Goods | 7,090 | 9,778 | 9,971 | 9,867 | 9,939 |
Gross Profit | 11,724 | 13,386 | 8,379 | 16,620 | 15,276 |
Operating Expenses | 20,163 | 25,248 | 30,935 | 26,926 | 27,766 |
Operating Income | -8,349 | -11,084 | -21,585 | -9,439 | -11,551 |
Interest Expense | 2,625 | 2,606 | 2,612 | 2,293 | 2,239 |
Other Income | 485 | 588 | 776 | 908 | 889 |
Pre-tax Income | -10,489 | -13,102 | -23,421 | -10,824 | -12,901 |
Income Tax | 44 | 47 | 63 | -22 | 15 |
Net Income Continuous | -10,533 | -13,149 | -23,484 | -10,802 | -12,916 |
Net Income | $-10,533 | $-13,149 | $-23,484 | $-10,802 | $-12,916 |
EPS Basic Total Ops | -0.21 | -0.27 | -0.48 | -0.17 | -0.26 |
EPS Basic Continuous Ops | -0.21 | -0.27 | -0.48 | -0.16 | -0.26 |
EPS Diluted Total Ops | -0.21 | -0.27 | -0.48 | -0.17 | -0.26 |
EPS Diluted Continuous Ops | -0.21 | -0.27 | -0.48 | -0.16 | -0.26 |
EPS Diluted Before Non-Recurring Items | N/A | -0.27 | -0.35 | -0.22 | -0.26 |
EBITDA(a) | $-6,524 | $-9,158 | $-19,534 | $-7,333 | $-8,975 |